@ivorytrial.bsky.social
📤 1
📥 13
📝 2
pinned post!
The IVORY trial was published in Nature Medicine last week.
rdcu.be/eX8W3
This trial done in high-risk individuals who presented with heart attacks 🫀, showed low-dose interleukin-2 led to a ⬆️ Regulatory T cells ⬇️ Arterial inflammation 🔥 ⬇️ trend in adverse cardiovascular outcomes ❤️🔥 at 2 years
about 1 month ago
0
0
0
reposted by
20 days ago
Thank you Irene Fernandez-Ruiz for this great piece of commentary in
@natrevcardiol.nature.com
on the IVORY trial published in
@natmed.nature.com
Main paper can be found here:
rdcu.be/eX8W3
@ziadmallat.bsky.social
@18fdg.bsky.social
@vpd-hlri.bsky.social
@medcambridge.bsky.social
add a skeleton here at some point
0
7
4
reposted by
Nature Reviews Cardiology
21 days ago
New online! Low-dose IL-2 therapy reduces arterial inflammation in acute coronary syndromes
#CardioSky
loading . . .
Low-dose IL-2 therapy reduces arterial inflammation in acute coronary syndromes
Nature Reviews Cardiology, Published online: 22 January 2026; doi:10.1038/s41569-026-01256-0Treatment with low-dose IL-2 increases regulatory T cell numbers and reduces arterial inflammation in patients with an acute coronary syndrome and residual systemic inflammation compared with placebo, according to findings from the IVORY trial.
http://dlvr.it/TQWC42
0
5
3
reposted by
Nature Medicine
26 days ago
In a phase 2 trial, low-dose interleukin-2 boosted regulatory T cells and reduced arterial inflammation in acute coronary syndrome patients compared to placebo.
https://www.nature.com/articles/s41591-025-04090-y
0
6
6
reposted by
25 days ago
Thank you Elisa Martini for featuring the IVORY trial published in
@natmed.nature.com
in Nature Portfolio’s Nature CVR 🫀 Main paper:
rdcu.be/eX8W3
Commentary:
rdcu.be/eYyG6
@jch403.bsky.social
@ziadmallat.bsky.social
@18fdg.bsky.social
@ivorytrial.bsky.social
@mallatlab.bsky.social
0
4
4
Thank you
@vpd-hlri.bsky.social
for the shout-out. Original article here:
rdcu.be/eX8W3
add a skeleton here at some point
about 1 month ago
0
0
0
The IVORY trial was published in Nature Medicine last week.
rdcu.be/eX8W3
This trial done in high-risk individuals who presented with heart attacks 🫀, showed low-dose interleukin-2 led to a ⬆️ Regulatory T cells ⬇️ Arterial inflammation 🔥 ⬇️ trend in adverse cardiovascular outcomes ❤️🔥 at 2 years
about 1 month ago
0
0
0
you reached the end!!
feeds!
log in
